Prevalence of cardiovascular risk factors and concentration of C-reactive protein in Type D personality persons without cardiovascular disease

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 18, Issue 3, 2011, Pages 504-509

  Einvik, Gunnar ^a,b   Dammen, Toril ^b,c   Hrubos Strøm, Harald ^a,b   Namtvedt, Silje K ^a   Randby, Anna ^a   Kristiansen, Håvard A ^a   Somers, Virend K ^d   Nordhus, Inger H ^e   Omland, Torbjørn ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

C reactive protein; Cardiovascular risk; Leisure time physical activity; Smoking; Type D personality

Indexed keywords

C REACTIVE PROTEIN; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; HEART RATE; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; OBESITY; PERSONALITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; SMOKING; TYPE D PERSONALITY;

BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NORWAY; PERSONALITY; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS;

EID: 79959252915     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826710389383     Document Type: Article

References (19)

1. Denollet J. Type D personality. A potential risk factor refined. J Psychosom Res 2000; 49: 255-266. (Pubitemid 32043663)
2. Denollet J and Pedersen SS. Prognostic value of Type D personality compared with depressive symptoms. Arch Intern Med 2008; 168: 431-432. (Pubitemid 351347135)
3. Pedersen SS, Denollet J, Ong AT, Sonnenschein K, Erdman RA, Serruys PW, et al. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality. Eur J Cardiovasc Prev Rehabil 2007; 14: 135-140.
4. Aquarius AE, Smolderen KG, Hamming JF, De Vries JP, Vriens PW and Denollet J. Type D personality and mortality in peripheral arterial disease: A pilot study. Arch Surg 2009; 144: 728-733.
5. Kupper N and Denollet J. Type D personality as a prognostic factor in heart disease: assessment and mediating mechanisms. J Pers Assess 2007; 89: 265-276. (Pubitemid 350274950)
6. Karlsson MR, Edstrom-Pluss C, Held C, Henriksson P, Billing E and Wallen NH. Effects of expanded cardiac rehabilitation on psychosocial status in coronary artery disease with focus on type D characteristics. J Behav Med 2007; 30: 253-261. (Pubitemid 46944798)
7. Williams L, O'Connor RC, Howard S, Hughes BM, Johnston DW, Hay JL, et al. Type-D personality mechanisms of effect: The role of health-related behavior and social support. J Psychosom Res 2008; 64: 63-69. (Pubitemid 350297304)
8. Mols F, Denollet J and Type D. personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. Health Qual Life Outcome 2010; 8: 9.
9. Hausteiner C, Klupsch D, Emeny R, Baumert J and Ladwig K for the KORA Investigators. Clustering of negative affectivity and social inhibition in the community: Prevalence of type D personality as a cardiovascular risk marker. Psychosom Med 2010; 72: 163-171.
10. Conraads VM, Denollet J, De Clerck LS, Stevens WJ, Bridts C and Vrints CJ. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int J Cardiol 2006; 113: 34-38. (Pubitemid 44648357)
11. Denollet J, Conraads VM, Brutsaert DL, De Clerck LS, Stevens WJ and Vrints CJ. Cytokines and immune activation in systolic heart failure: the role of Type D personality. Brain Behav Immun 2003; 17: 304-309. (Pubitemid 36794151)
12. Calvin AD and Somers VK. Obstructive sleep apnea and cardiovascular disease. Curr Opin Cardiol 2009; 24: 516-520.
13. Netzer NC, Stoohs RA, Netzer CM, Clark K and Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131: 485-491. (Pubitemid 29482391)
14. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005; 67: 89-97.
15. Naess O, Sogaard AJ, Arnesen E, Beckstrom AC, Bjertness E, Engeland A, et al. Cohort profile: cohort of Norway (CONOR). Int J Epidemiol 2008; 37: 481-485. (Pubitemid 351804000)
16. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14: S1-S113. (Pubitemid 47339826)
17. Cooney MT, Vartiainen E, Laakitainen T, Juolevi A, Dudina A and Graham IM. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 2010; 159: 612-619.
18. Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC and Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol 2010; 105: 905-911.
19. Denollet J and Kupper N. Type-D personality, depression, and cardiac prognosis: cortisol dysregulation as a mediating mechanism. J Psychosom Res 2007; 62: 607-609. (Pubitemid 46809922)